Nervonic acid amends motor disorder in a mouse model of Parkinson’s disease

Articles in the same Issue

1. Research Articles
2. Mice can recognise water depths and will avoid entering deep water
3. CLSPCOL rescues Alzheimer’s disease mouse models
4. Ischemic stroke following STA–MCA double bypass
5. Relationship between subclasses low-density lipoprotein and carotid plaque
6. Construction and effect evaluation of different sciatic nerve injury models in rats
7. Effects of propofol on neuroblastoma cells via the HOTAIRM1/miR-519a-3p axis
8. Effects of Goldblatt hypertension on rats’ hippocampal cholinergic system
9. Longitudinal PET studies of mGluR5 in FXS using an FMR1 knockout mouse model
10. Molecular recognition of the interaction between ApoE and the TREM2 protein
11. Remimazolam induced cognitive dysfunction in mice via glutamate excitotoxicity
12. Hybrid ¹⁸F-florbetapir PET/MRI for assessing myelin recovery in GFAP-A patients
13. Preliminary study on pathogenic mechanism of first Chinese family with PNKD
14. Aged rats learn Morris Water maze using non-spatial search strategies evidenced by a parameter-based algorithm
15. Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
16. The roles and diagnostic value of miRNA-1246 in the serum of patients with intracranial aneurysms
17. Predictors of high dose of massed practice following stroke
18. The effect of stimulation frequency on transcranial evoked potentials
19. Increased levels of neurofilament light chain in suicide attempters’ serum
20. Propofol ameliorates ischemic brain injury by blocking TLR4 pathway in mice
21. Single-cell analysis of gene expression in the substantia nigra pars compacta of a pesticide-induced mouse model of Parkinson’s disease
22. Psychobiotics improve propionic acid-induced neuroinflammation in juvenile rats, rodent model of autism
23. Isoliquiritigenin attenuates neuroinflammation in mice model of Parkinson’s disease by promoting Nrf2/NQO-1 pathway
24. Ketamine alleviating depressive-like behaviors is associated with regulation of nNOS–CAPON–Dexras1 complex in chronic unpredictable mild stress rats
25. The association of anxiety and other clinical features with CACNA1C rs1006737 in patients with depression
26. Outcomes of acute ischemic stroke in kidney transplant recipients: An analysis of US Nationwide inpatient sample
27. Brain atrophy pattern in patients with mild cognitive impairment: MRI study
28. Correlation of serum RBP4 level with oxidative stress and unstable carotid plaque in patients with cerebral infarction
29. Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia
30. Protection against H₂O₂-evoked toxicity in HT22 hippocampal neuronal cells by geissoschizine methyl ether via inhibiting ERK pathway
31. Alteration in NMDAR subunits in different brain regions of chronic unpredictable mild stress (CUMS) rat model
32. Acacetin improves cognitive function of APP/PS1 Alzheimer’s disease model mice via the NLRP3 inflammasome signaling pathway
33. Assessment of malformations, variations and diameters of vessels forming the circle of Willis – An autopsy study in a non-cerebrovascular cohort
34. Singular versus combinatory glucose-sensitive signal control of metabolic sensor protein profiles in hypothalamic astrocyte cultures from each sex
35. Mild acute stress prevents the memory impairment induced by long-term isoflurane anesthesia
36. Esketamine improves propofol-induced brain injury and cognitive impairment in rats
37. Correlations between EEG and intestinal electrical stimulation
38. Factors influencing recovery of upper limb motor function during constraint-induced movement therapy for people with stroke
39. Application of auditory mismatch negativity in tinnitus patients based on high-resolution electroencephalogram signals
40. The value of transcranial Doppler monitoring of cerebral blood flow changes during carotid endarterectomy performed under regional anesthesia – A case series
41. Acacetin alleviates neuroinflammation and oxidative stress injury via the Nrf2/HO-1 pathway in a mouse model of spinal cord injury
42. Pre-ischemic exercise prevents inflammation and apoptosis by inhibiting MAPK pathway in ischemic stroke
43. Fronto-parietal single-trial brain connectivity benefits successful memory recognition
44. Review Articles
45. Machine learning approaches for diagnosing depression using EEG: A review
46. Perinatal diet and offspring anxiety: A scoping review
47. Brain and gut microbiota disorders in the psychopathology of anorexia nervosa
48. Nanotechnology-based drug delivery for the treatment of CNS disorders
49. Case Reports
50. A rare giant intracranial arachnoid cyst confused the diagnosis and treatment of Wilson disease
51. Cerebral infarction following bee stings: Case report and literature review
52. Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach
53. Long-acting paliperidone in Ekbom’s syndrome in Lewy body dementia: A case report
54. Patients with post-COVID-19 vaccination facial palsy: To boost or not to boost?
55. Autosomal dominant sleep-related hypermotor epilepsy associated with a novel mutation of KCNT1
56. A rare brainstem anaplastic astrocytoma
57. A singular case of hyposmia and transient audiovestibular post-vaccine disorders: case report and literature review
58. A rare lymphoplasmacyte-rich meningioma involving the dura of the skull base and cervical spinal cord: A case report
59. Communication
60. The system’s genetics of depression and its somatic and mental comorbidities
61. Commentary
62. The possible association between neurodegenerative/demyelinating neurological disorders in achalasia patients
63. Letter to the Editor
64. A patient with hereditary transthyretin amyloidosis involving multiple cranial nerves due to a rare p.(Phe84Ser) variant
65. Erratum
66. Erratum to “Spinocerebellar ataxia type 40: A case report and literature review”
67. Erratum to “Construction and effect evaluation of different sciatic nerve injury models in rats”
68. Retraction
69. Nervonic acid amends motor disorder in a mouse model of Parkinson’s disease
70. Retraction of “Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling”